AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
31.37
+0.19 (0.61%)
May 9, 2025, 10:13 AM - Market open
AtriCure Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for AtriCure stock have an average target of 49.6, with a low estimate of 40 and a high estimate of 60. The average target predicts an increase of 58.11% from the current stock price of 31.37.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AtriCure stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $60 → $58 | Strong Buy | Maintains | $60 → $58 | +84.89% | Apr 30, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $60 | Buy | Reiterates | $60 | +91.27% | Apr 30, 2025 |
| Needham | Needham | Strong Buy Maintains $51 → $44 | Strong Buy | Maintains | $51 → $44 | +40.26% | Apr 30, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $60 | Buy | Reiterates | $60 | +91.27% | Apr 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $66 → $52 | Strong Buy | Maintains | $66 → $52 | +65.76% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
533.25M
from 465.31M
Increased by 14.60%
Revenue Next Year
600.31M
from 533.25M
Increased by 12.58%
EPS This Year
-0.67
from -0.95
EPS Next Year
-0.42
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 554.1M | 639.2M | 728.6M | ||
| Avg | 533.3M | 600.3M | 680.7M | ||
| Low | 510.2M | 563.5M | 630.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.1% | 19.9% | 21.4% | ||
| Avg | 14.6% | 12.6% | 13.4% | ||
| Low | 9.6% | 5.7% | 5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.51 | -0.27 | 0.14 | ||
| Avg | -0.67 | -0.42 | -0.04 | ||
| Low | -0.85 | -0.56 | -0.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.